Induction of necroptosis in lung adenocarcinoma by miR‑10b‑5p through modulation of the PKP3/RIPK3/MLKL cascade

Hu,Ying; Liu,Xin; Yuan,Ziheng; He,Jianping; Ma,Run; Wang,Yuming; Yi,Genfa

doi:10.3892/or.2025.8889

May-2025 Volume 53 Issue 5

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

May-2025 Volume 53 Issue 5

Full Size Image

Article Open Access

Induction of necroptosis in lung adenocarcinoma by miR‑10b‑5p through modulation of the PKP3/RIPK3/MLKL cascade

Authors:
- Ying Hu
- Xin Liu
- Ziheng Yuan
- Jianping He
- Run Ma
- Yuming Wang
- Genfa Yi
View Affiliations / Copyright

Affiliations: Department of Laboratory, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650101, P.R. China, Department of Thoracic Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650101, P.R. China, Department of Medical Genetics and Prenatal Diagnosis, Kunming Maternal and Child Health Centre, Kunming, Yunnan 650032, P.R. China, Department of Medical Imaging, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan 650051, P.R. China

Copyright: © Hu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Article Number: 56
|
Published online on: March 20, 2025

https://doi.org/10.3892/or.2025.8889
Expand metrics +

Abstract

Globally, lung adenocarcinoma (LUAD) remains the leading cause of cancer‑related mortality, highlighting the urgent need for innovative therapeutic approaches. Necroptosis has been recognized as a crucial mechanism for inhibiting cancer progression. Research has revealed a significant association between microRNA (miRNA)‑mediated necroptosis and tumor progression. The present study aimed to elucidate the role and underlying mechanisms of miR‑10b‑5p in regulating necroptosis in the context of LUAD. In an investigation of LUAD, miRNA sequencing was conducted on both LUAD and adjacent non‑tumor tissues, followed by the integration of external database information to identify specific target miRNAs. The expression of miR‑10b‑5p was verified in LUAD tissues and corresponding adjacent non‑cancerous tissues using immunohistochemistry. In vitro experiments, utilizing LUAD cell lines engineered to modulate miR‑10b‑5p levels, assessed its effects on cellular activities and necroptosis. The inhibition of PKP3 by miR‑10b‑5p was determined using a dual luciferase reporter system. Furthermore, alterations in miR‑10b‑5p levels were found to affect PKP3 expression and inhibit the RIPK3/MLKL signaling pathway, as evidenced by western blot analysis in LUAD cell lines. The effect of PKP3 knockdown on cell activity and necroptosis in LUAD cell lines with low miR‑10b‑5p expression levels was assessed using cell function assays. Finally, a nude mouse xenograft model was used to investigate the effect of miR‑10b‑5p on LUAD growth in vivo and its specific mechanism of action. It has been revealed that miR‑10b‑5p levels are significantly elevated in LUAD specimens. Further investigations demonstrated that an increase in miR‑10b‑5p enhances the proliferation of LUAD cells and suppresses the progression of necroptosis, as evidenced by in vitro experiments. Through dual luciferase reporter assays, PKP3 was confirmed as a direct target negatively regulated by miR‑10b‑5p, leading to reduced expression levels. Western blot analysis indicated that miR‑10b‑5p inhibits the RIPK3/MLKL pathway activation through downregulation of PKP3, which leads to increased cell proliferation and decreased necroptosis. However, knockdown of PKP3 reversed the inhibitory effect of miR‑10b‑5p inhibitors on cellular activity and inhibited necrosis by suppressing the RIPK3/MLKL signalling pathway. In addition, animal model studies demonstrated that inhibition of miR‑10b‑5p activated the RIPK3/MLKL pathway by promoting PKP3 expression and significantly reduced LUAD growth by promoting necroptosis. In conclusion, our studies have revealed that the miR‑10b‑5p functions as a tumorigenic factor, enhancing various cellular activities in LUAD cells and suppressing necroptosis by specifically targeting PKP3, thereby inhibiting activation of the RIPK3/MLKL pathway. Importantly, interventions using inhibitors that specifically target miR‑10b‑5p have shown significant success in impeding the progression of LUAD by promoting necroptosis in both cellular and animal models. Thus, targeting miR‑10b‑5p holds considerable potential as a therapeutic strategy for LUAD.

View Figures

View References

1	Zhao B, Xu H, Ai X, Adalat Y, Tong Y, Zhang J and Yang S: Expression profiles of long noncoding RNAs in lung adenocarcinoma. Onco Targets Ther. 11:5383–5390. 2018. View Article : Google Scholar : PubMed/NCBI
2	Wei X, Li X, Hu S, Cheng J and Cai R: Regulation of ferroptosis in lung adenocarcinoma. Int J Mol Sci. 24:146142023. View Article : Google Scholar : PubMed/NCBI
3	Denisenko TV, Budkevich IN and Zhivotovsky B: Cell death-based treatment of lung adenocarcinoma. Cell Death Dis. 9:1172018. View Article : Google Scholar : PubMed/NCBI
4	Chen H, Xia R, Jiang L, Zhou Y, Xu H, Peng W, Yao C, Zhou G, Zhang Y, Xia H and Wang Y: Overexpression of RhoV promotes the progression and EGFR-TKI resistance of lung adenocarcinoma. Front Oncol. 11:6190132021. View Article : Google Scholar : PubMed/NCBI
5	Li S, Choi YL, Gong Z, Liu X, Lira M, Kan Z, Oh E, Wang J, Ting JC, Ye X, et al: Comprehensive characterization of oncogenic drivers in asian lung adenocarcinoma. J Thorac Oncol. 11:2129–2140. 2016. View Article : Google Scholar : PubMed/NCBI
6	Zhang Y, Chen J, Tian J, Zhou Y and Liu Y: Role and function of plakophilin 3 in cancer progression and skin disease. Cancer Sci. 115:17–23. 2024. View Article : Google Scholar : PubMed/NCBI
7	Du Y, Hou S, Chen Z, Li W, Li X and Zhou W: Comprehensive analysis identifies PKP3 overexpression in pancreatic cancer related to unfavorable prognosis. Biomedicines. 11:24722023. View Article : Google Scholar : PubMed/NCBI
8	Lim V, Zhu H, Diao S, Hu L and Hu J: PKP3 interactions with MAPK-JNK-ERK1/2-mTOR pathway regulates autophagy and invasion in ovarian cancer. Biochem Biophys Res Commun. 508:646–653. 2019. View Article : Google Scholar : PubMed/NCBI
9	Liu B, Feng Y, Xie N, Yang Y and Yang D: FERMT1 promotes cell migration and invasion in non-small cell lung cancer via regulating PKP3-mediated activation of p38 MAPK signaling. BMC Cancer. 24:582024. View Article : Google Scholar : PubMed/NCBI
10	Lee LYW, Woolley C, Starkey T, Biswas S, Mirshahi T, Bardella C, Segditsas S, Irshad S and Tomlinson I: Serum- and Glucocorticoid-induced kinase sgk1 directly promotes the differentiation of colorectal cancer cells and restrains metastasis. Clin Cancer Res. 25:629–640. 2019. View Article : Google Scholar : PubMed/NCBI
11	Takahashi H, Nakatsuji H, Takahashi M, Avirmed S, Fukawa T, Takemura M, Fukumori T and Kanayama H: Up-regulation of plakophilin-2 and Down-regulation of plakophilin-3 are correlated with invasiveness in bladder cancer. Urology. 79:240.e1–e8. 2012. View Article : Google Scholar : PubMed/NCBI
12	Furukawa C, Daigo Y, Ishikawa N, Kato T, Ito T, Tsuchiya E, Sone S and Nakamura Y: Plakophilin 3 oncogene as prognostic marker and therapeutic target for lung cancer. Cancer Res. 65:7102–7110. 2005. View Article : Google Scholar : PubMed/NCBI
13	Liu Z, Wang T, She Y, Wu K, Gu S, Li L, Dong C, Chen C and Zhou Y: N6-methyladenosine-modified circIGF2BP3 inhibits CD8+ T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer. Mol Cancer. 20:1052021. View Article : Google Scholar : PubMed/NCBI
14	Kim HJ, Roh MS, Son CH, Kim AJ, Jee HJ, Song N, Kim M, Seo SY, Yoo YH and Yun J: Loss of Med1/TRAP220 promotes the invasion and metastasis of human non-small-cell lung cancer cells by modulating the expression of metastasis-related genes. Cancer Lett. 321:195–202. 2012. View Article : Google Scholar : PubMed/NCBI
15	Qin X, Ma D, Tan YX, Wang HY and Cai Z: The role of necroptosis in cancer: A double-edged sword? Biochim Biophys Acta Rev Cancer. 1871:259–266. 2019. View Article : Google Scholar : PubMed/NCBI
16	Zhu F, Zhang W, Yang T and He SD: Complex roles of necroptosis in cancer. J Zhejiang Univ Sci B. 20:399–413. 2019. View Article : Google Scholar : PubMed/NCBI
17	Philipp S, Sosna J and Adam D: Cancer and necroptosis: Friend or foe? Cell Mol Life Sci. 73:2183–2193. 2016. View Article : Google Scholar : PubMed/NCBI
18	Hayes J, Peruzzi PP and Lawler S: MicroRNAs in cancer: Biomarkers, functions and therapy. Trends Mol Med. 20:460–469. 2014. View Article : Google Scholar : PubMed/NCBI
19	Su Z, Yang Z, Xu Y, Chen Y and Yu Q: MicroRNAs in apoptosis, autophagy and necroptosis. Oncotarget. 6:8474–8490. 2015. View Article : Google Scholar : PubMed/NCBI
20	Harari-Steinfeld R, Gefen M, Simerzin A, Zorde-Khvalevsky E, Rivkin M, Ella E, Friehmann T, Gerlic M, Zucman-Rossi J, Caruso S, et al: The lncRNA H19-Derived MicroRNA-675 promotes liver necroptosis by targeting FADD. Cancers (Basel). 13:4112021. View Article : Google Scholar : PubMed/NCBI
21	Li X, Tibenda JJ, Nan Y, Huang SC, Ning N, Chen GQ, Du YH, Yang YT, Meng FD and Yuan L: MiR-204-3p overexpression inhibits gastric carcinoma cell proliferation by inhibiting the MAPK pathway and RIP1/MLK1 necroptosis pathway to promote apoptosis. World J Gastroenterol. 29:4542–4556. 2023. View Article : Google Scholar : PubMed/NCBI
22	Yan T, Wang X, Wei G, Li H, Hao L, Liu Y, Yu X, Zhu W, Liu P, Zhu Y and Zhou X: Exosomal miR-10b-5p mediates cell communication of gastric cancer cells and fibroblasts and facilitates cell proliferation. J Cancer. 12:2140–2150. 2021. View Article : Google Scholar : PubMed/NCBI
23	Xia M, Chen J, Hu Y, Qu B, Bu Q and Shen H: miR-10b-5p promotes tumor growth by regulating cell metabolism in liver cancer via targeting SLC38A2. Cancer Biol Ther. 25:23156512024. View Article : Google Scholar : PubMed/NCBI
24	Li S, Mao L, Song L, Xia X, Wang Z, Cheng Y, Lai J, Tang X and Chen X: Extracellular vesicles derived from glioma stem cells affect glycometabolic reprogramming of glioma cells through the miR-10b-5p/PTEN/PI3K/Akt pathway. Stem Cell Rev Rep. 20:779–796. 2024. View Article : Google Scholar : PubMed/NCBI
25	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
26	Song Y, Kelava L and Kiss I: MiRNAs in lung adenocarcinoma: Role, diagnosis, prognosis, and therapy. Int J Mol Sci. 24:133022023. View Article : Google Scholar : PubMed/NCBI
27	Liu J, Zhang F, Wang J and Wang Y: MicroRNA-mediated regulation in lung adenocarcinoma: Signaling pathways and potential therapeutic implications (Review). Oncol Rep. 50:2112023. View Article : Google Scholar : PubMed/NCBI
28	Molina JR, Yang P, Cassivi SD, Schild SE and Adjei AA: Non-small cell lung cancer: Epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 83:584–594. 2008. View Article : Google Scholar : PubMed/NCBI
29	Lee RC, Feinbaum RL and Ambros V: The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 75:843–854. 1993. View Article : Google Scholar : PubMed/NCBI
30	Ambros V: The functions of animal microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
31	Du W, Chen D, Wei K, Yu D, Gan Z, Xu G and Yao G: MiR-10b-5p impairs TET2-Mediated inhibition of PD-L1 transcription thus promoting immune evasion and tumor progression in glioblastoma. Tohoku J Exp Med. 260:205–214. 2023. View Article : Google Scholar : PubMed/NCBI
32	Zhou Y, Xiang Y, Liu S, Li C, Dong J, Kong X, Ji X, Cheng X and Zhang L: RIPK3 signaling and its role in regulated cell death and diseases. Cell Death Discov. 10:2002024. View Article : Google Scholar : PubMed/NCBI
33	Yuan J and Ofengeim D: A guide to cell death pathways. Nat Rev Mol Cell Biol. 25:379–395. 2024. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Induction of necroptosis in lung adenocarcinoma by miR‑10b‑5p through modulation of the PKP3/RIPK3/MLKL cascade

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Related Articles